There are many ongoing advances in patient safety in the context of radiation therapy delivery, clinical research on treatment options, and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.

It is important that surgeons recognize the extent of surgery needed for the primary tumor and cervical lymphatics in upfront management of salivary gland cancer. Attendees need to recognize the emerging role of systemic therapy in management of salivary cancer and determine what molecular markers help guide therapy. Radiation oncologists need to understand indications for adjuvant radiation therapy following surgery for salivary cancer and when the use of specialized radiation approaches such as proton therapy may be indicated.

This case-based tumor board presents patients with different types of salivary cancer. The goals of the session are to outline the extent of surgery needed in upfront management of salivary cancer, the indications for adjuvant radiation therapy and when special techniques are utilized, and the emerging role of molecular profiling for designing systemic treatment in patients with advanced recurrent/metastatic disease. The cases presented are meant to be the foundation for an open discussion with our panel of experts and there will be an opportunity for audience questions/comments.